Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:PBENYSEARCA:PJPNYSEARCA:XHENYSEARCA:XPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePBEInvesco Biotechnology & Genome ETF$65.66+0.4%$63.07$54.52▼$72.84$228.50M0.877,609 shs2,487 shsPJPInvesco Pharmaceuticals ETF$81.38+0.1%$80.37$72.25▼$89.87$236.00M0.668,749 shs2,389 shsXHESPDR S&P Health Care Equipment ETF$81.85+0.2%$81.00$71.25▼$97.10$169.84M0.9415,460 shs3,133 shsXPHSPDR S&P Pharmaceuticals ETF$41.28+0.1%$40.74$35.22▼$48.76$150.67M0.8448,538 shs22,914 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePBEInvesco Biotechnology & Genome ETF0.00%+1.99%+0.51%+12.11%+1.66%PJPInvesco Pharmaceuticals ETF0.00%+2.01%-0.23%+4.74%+0.94%XHESPDR S&P Health Care Equipment ETF0.00%+1.20%-0.43%+8.89%-2.51%XPHSPDR S&P Pharmaceuticals ETF0.00%+1.60%-1.57%+7.56%+4.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPBEInvesco Biotechnology & Genome ETFN/AN/AN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/AN/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePBEInvesco Biotechnology & Genome ETF 2.71Moderate Buy$65.66N/APJPInvesco Pharmaceuticals ETF 2.67Moderate Buy$81.38N/AXHESPDR S&P Health Care Equipment ETF 2.68Moderate Buy$81.85N/AXPHSPDR S&P Pharmaceuticals ETF 2.71Moderate Buy$41.28N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPBEInvesco Biotechnology & Genome ETFN/AN/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePBEInvesco Biotechnology & Genome ETFN/AN/A18.88∞N/AN/AN/AN/AN/APJPInvesco Pharmaceuticals ETFN/AN/A16.14∞N/AN/AN/AN/AN/AXHESPDR S&P Health Care Equipment ETFN/AN/A29.20∞N/AN/AN/AN/AN/AXPHSPDR S&P Pharmaceuticals ETFN/AN/A14.28∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPBEInvesco Biotechnology & Genome ETF$0.160.24%N/AN/AN/APJPInvesco Pharmaceuticals ETF$0.961.18%N/AN/AN/AXHESPDR S&P Health Care Equipment ETF$0.050.06%N/AN/AN/AXPHSPDR S&P Pharmaceuticals ETF$0.591.43%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/AXHESPDR S&P Health Care Equipment ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/AInsider OwnershipCompanyInsider OwnershipPBEInvesco Biotechnology & Genome ETFN/APJPInvesco Pharmaceuticals ETFN/AXHESPDR S&P Health Care Equipment ETFN/AXPHSPDR S&P Pharmaceuticals ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePBEInvesco Biotechnology & Genome ETFN/A3.48 millionN/ANot OptionablePJPInvesco Pharmaceuticals ETFN/A2.90 millionN/ANot OptionableXHESPDR S&P Health Care Equipment ETFN/A2.08 millionN/ANot OptionableXPHSPDR S&P Pharmaceuticals ETFN/A3.65 millionN/ANot OptionablePBE, PJP, XHE, and XPH HeadlinesRecent News About These CompaniesSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0959June 23, 2025 | msn.comShort bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted rankingMay 15, 2025 | msn.comETFs on the Move Post U.S.-China Trade DealMay 12, 2025 | zacks.comA Look at Pharma ETFs After Strong Q1 EarningsMay 8, 2025 | zacks.comCapture European Growth with This Banking-Focused ETFApril 22, 2025 | theglobeandmail.comSPDR S&P Biotech ETF declares quarterly distribution of $0.0053March 24, 2025 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1548December 23, 2024 | msn.comSPDR® S&P Regional Banking ETFDecember 20, 2024 | morningstar.comM1 No-Brainer Small-Cap S&P Index Fund to Buy Right Now for Less Than $200November 21, 2024 | msn.comShuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per shareOctober 30, 2024 | markets.businessinsider.comBalanced Outlook on Apellis Pharmaceuticals: Promising Empaveli Data Amid Syfovre Growth ChallengesOctober 28, 2024 | markets.businessinsider.comBristol Myers Squibb: A High-Yield Bargain With Growth On The HorizonOctober 6, 2024 | seekingalpha.comBottom-up default shifts significantly lower for telecoms, pharma; higher for techAugust 30, 2024 | msn.comPharma ETFs in Focus Post Solid Q2 EarningsAugust 14, 2024 | zacks.comIs SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?July 24, 2024 | zacks.comShould You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?July 17, 2024 | zacks.comFinding Opportunity in Unloved Healthcare ETFsMay 31, 2024 | etftrends.comEShould You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?May 16, 2024 | zacks.com5 Beaten-Down Top-Ranked ETFs to Buy for a TurnaroundMay 14, 2024 | zacks.comA Look at Pharma ETFs Post Q1 EarningsMay 7, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePBE, PJP, XHE, and XPH Company DescriptionsInvesco Biotechnology & Genome ETF NYSEARCA:PBE$65.66 +0.23 (+0.35%) As of 07/3/2025 05:00 PM EasternPowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Invesco Pharmaceuticals ETF NYSEARCA:PJP$81.38 +0.09 (+0.11%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$81.37 -0.01 (-0.01%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.SPDR S&P Health Care Equipment ETF NYSEARCA:XHE$81.85 +0.13 (+0.16%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$81.80 -0.05 (-0.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of U.S. health care equipment and supplies companies. XHE was launched on Jan 26, 2011 and is managed by State Street.SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH$41.28 +0.05 (+0.12%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$41.26 -0.02 (-0.05%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
